Skip to main content
. 2020 Sep 17;8(18):e14566. doi: 10.14814/phy2.14566

FIGURE 3.

FIGURE 3

SnPP administration increases plasma TGFβ1 concentrations in healthy volunteers, but not in CKD subjects. Baseline TGFβ1 levels did not differ between the healthy volunteer and the CKD groups. SnPP administration induced an approximate 75% increase in plasma TGFβ1 levels in healthy subjects whereas no response was observed in the CKD cohort